Your browser doesn't support javascript.
loading
Surgical strategies for older patients with glioblastoma.
Barak, Tanyeri; Vetsa, Shaurey; Nadar, Arushii; Jin, Lan; Gupte, Trisha P; Fomchenko, Elena I; Miyagishima, Danielle F; Yalcin, Kanat; Vasandani, Sagar; Gorelick, Evan; Zhao, Amy Y; Antonios, Joseph; Theriault, Brianna Carusillo; Lifton, Nathan; Marianayagam, Neelan; Omay, Bulent; Omay, Zeynep Erson; Huttner, Anita; McGuone, Declan; Blondin, Nicholas A; Corbin, Zachary; Fulbright, Robert K; Moliterno, Jennifer.
Afiliación
  • Barak T; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Vetsa S; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Nadar A; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
  • Jin L; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Gupte TP; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Fomchenko EI; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Miyagishima DF; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Yalcin K; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Vasandani S; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Gorelick E; Department of Surgery, Yale School of Medicine, New Haven, USA.
  • Zhao AY; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, USA.
  • Antonios J; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Theriault BC; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Lifton N; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Marianayagam N; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Omay B; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Omay ZE; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Huttner A; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • McGuone D; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Blondin NA; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Corbin Z; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
  • Fulbright RK; Yale Brain Tumor Center, Smilow Cancer Hospital, CT, New Haven, USA.
  • Moliterno J; Department of Neurosurgery, Yale School of Medicine, 15 York St., LLCI 810, CT, 06520-8082, New Haven, USA.
J Neurooncol ; 155(3): 255-264, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34626296
ABSTRACT

OBJECTIVE:

While adjuvant treatment regimens have been modified for older patients with glioblastoma (GBM), surgical strategies have not been tailored.

METHODS:

Clinical data of 48 consecutive patients aged 70 years or older, who underwent surgical resection for GBM with intraoperative ultrasonography (IoUS) alone or combination with intraoperative MRI (IoMRI) at Yale New Haven Hospital were retrospectively reviewed. Variables were analyzed, and comparative analyses were performed.

RESULTS:

The addition of IoMRI was not superior to IoUS alone in terms of overall survival (OS) (P = 0.306), Karnofsky Performance Score (KPS) at postoperative 6 weeks (P = 0.704) or extent of resection (P = 0.263). Length of surgery (LOSx), however, was significantly longer (P = 0.0002) in the IoMRI group. LOSx (P = 0.015) and hospital stay (P = 0.025) were predictors of postoperative complications. Increased EOR (GTR or NTR) (P = 0.030), postoperative adjuvant treatment (P < 0.0001) and postoperative complications (P = 0.006) were predictive for OS. Patients with relatively lower preoperative KPS scores (<70) showed significant improvement at postoperative 6 weeks (P<0.0001). Patients with complications (P = 0.038) were more likely to have lower KPS at postoperative 6 weeks.

CONCLUSIONS:

Aggressive management with surgical resection should be considered in older patients with GBM, even those with relatively poor KPS. The use of ioMRI in this population does not appear to confer any measurable benefit over ioUS in experienced hands, but prolongs the length of surgery significantly, which is a preventable prognostic factor for impeding care.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: J Neurooncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: J Neurooncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...